Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senthil Natesan

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|September 6, 2022
Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and AnalogsPeter Obi, Senthil Natesan
Current Pharmaceutical Design|November 23, 2012
Rigorous incorporation of tautomers, ionization species, and different binding modes into ligand-based and receptor-based 3D-QSAR methodsSenthil Natesan, Stefan Balaz
Biorxiv : the Preprint Server for Biology|October 10, 2024
Structural insights into the molecular recognition of integrin αVβ3 by RGD-containing ligands: The role of the specificity-determining loop (SDL)Charles Mariasoosai, Santanu Bose, Senthil Natesan
Molecular Pharmacology|April 11, 2019
Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?Christopher T Szlenk, Jeevan B Gc, Senthil Natesan
Journal of Medicinal Chemistry|January 28, 2012
Binding affinity prediction for ligands and receptors forming tautomers and ionization species: inhibition of mitogen-activated protein kinase-activated protein kinase 2 (MK2)Senthil Natesan, Rajesh Subramaniam, Charles Bergeron, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Determination of alternative ceftolozane/tazobactam dosing regimens for patients with infections due to Pseudomonas aeruginosa with MIC values between 4 and 32 mg/LSenthil Natesan, Manjunath P Pai, Thomas P Lodise
Molecular Pharmacology|August 2, 2021
Membrane-Facilitated Receptor Access and Binding Mechanisms of Long-Acting <i>β</i>2-Adrenergic Receptor AgonistsChristopher T Szlenk, Jeevan B Gc, Senthil Natesan
Biorxiv : the Preprint Server for Biology|October 10, 2024
Structural basis for the access and binding of resolvin D1 (RvD1) to formyl peptide receptor 2 (FPR2/ALX), a class A GPCRBrian Mun, Peter Obi, Christopher T Szlenk, et al.
Clinical and Translational Science|November 3, 2018
Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory AnalysisDan-Dan Tian, Senthil Natesan, John R White, et al.
Journal of Chemical Information and Modeling|May 25, 2026
Open-State Dynamics and Allosteric Modulation of the α1β3γ2 GABA<sub>A</sub> Receptor Stabilized by L9'T/S SubstitutionsAyobami Diyaolu, Cecilia M Borghese, Marcel P Goldschen-Ohm, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|September 6, 2022
Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and AnalogsPeter Obi, Senthil Natesan
Current Pharmaceutical Design|November 23, 2012
Rigorous incorporation of tautomers, ionization species, and different binding modes into ligand-based and receptor-based 3D-QSAR methodsSenthil Natesan, Stefan Balaz
Biorxiv : the Preprint Server for Biology|October 10, 2024
Structural insights into the molecular recognition of integrin αVβ3 by RGD-containing ligands: The role of the specificity-determining loop (SDL)Charles Mariasoosai, Santanu Bose, Senthil Natesan
Molecular Pharmacology|April 11, 2019
Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?Christopher T Szlenk, Jeevan B Gc, Senthil Natesan
Journal of Medicinal Chemistry|January 28, 2012
Binding affinity prediction for ligands and receptors forming tautomers and ionization species: inhibition of mitogen-activated protein kinase-activated protein kinase 2 (MK2)Senthil Natesan, Rajesh Subramaniam, Charles Bergeron, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Determination of alternative ceftolozane/tazobactam dosing regimens for patients with infections due to Pseudomonas aeruginosa with MIC values between 4 and 32 mg/LSenthil Natesan, Manjunath P Pai, Thomas P Lodise
Molecular Pharmacology|August 2, 2021
Membrane-Facilitated Receptor Access and Binding Mechanisms of Long-Acting <i>β</i>2-Adrenergic Receptor AgonistsChristopher T Szlenk, Jeevan B Gc, Senthil Natesan
Biorxiv : the Preprint Server for Biology|October 10, 2024
Structural basis for the access and binding of resolvin D1 (RvD1) to formyl peptide receptor 2 (FPR2/ALX), a class A GPCRBrian Mun, Peter Obi, Christopher T Szlenk, et al.
Clinical and Translational Science|November 3, 2018
Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory AnalysisDan-Dan Tian, Senthil Natesan, John R White, et al.
Journal of Chemical Information and Modeling|May 25, 2026
Open-State Dynamics and Allosteric Modulation of the α1β3γ2 GABA<sub>A</sub> Receptor Stabilized by L9'T/S SubstitutionsAyobami Diyaolu, Cecilia M Borghese, Marcel P Goldschen-Ohm, et al.
Pageof 7